Related Experiment Video
Updated: Jul 2, 2026

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
Congenital CMV infection: prevalence in newborns and the impact on hearing deficit
Mona-Lisa Engman1, Gunilla Malm, Lotta Engstrom
1Division of Clinical Microbiology, Karolinska University Hospital, Huddinge, Sweden. mona-lisa.engman@ki.se
Insights
Congenital cytomegalovirus (CMV) infection, often asymptomatic in newborns, significantly increases the risk of hearing loss. Early detection and surveillance are crucial for managing potential long-term health impacts in infants.
Area of Science:
- Pediatrics
- Infectious Diseases
- Audiology
Background:
- Congenital cytomegalovirus (CMV) infection is common in newborns, with most cases being asymptomatic.
- A significant minority of infected infants (10-20%) develop long-term sequelae, primarily hearing deficits.
- The impact of congenital CMV on child health can be easily underestimated due to the lack of neonatal symptoms.
Purpose of the Study:
- To determine the prevalence of congenital CMV infection in a Swedish newborn population.
- To investigate the association between congenital CMV infection and the risk of hearing deficit in newborns.
Main Methods:
- Analysis of dried blood spot (DBS) samples from 6060 newborns using TaqMan-based real-time PCR for CMV DNA.
- Hearing deficit assessment via otoacoustic emission (OAE) as part of a routine newborn screening program.
- Follow-up for ocular complications over three years.
Main Results:
- Congenital CMV infection was detected in 0.2% (12 out of 6060) of newborns.
- One infected infant developed unilateral hearing loss, indicating a substantially increased risk (approximately 20-fold) of hearing deficit.
- No ocular complications, such as chorioretinopathy, were observed in the follow-up period.
Conclusions:
- Congenital CMV infection poses a significant risk for hearing impairment in infants, even when asymptomatic at birth.
- Routine surveillance for congenital CMV is essential, complementing existing newborn screening and prevention programs.
- Early identification and management are vital for mitigating the long-term health consequences of congenital CMV.
Abstract:
Congenital cytomegalovirus (CMV) infection is asymptomatic in 90% of infected newborns but approximately 10-20% of these infants are at risk of developing sequelae later, mostly hearing deficit. The aims of the study were to investigate the prevalence of congenital CMV infection in a Swedish population of newborns and investigate the relative risk of hearing deficit in newborns with congenital CMV infection. The dried blood spot (DBS) samples of 6060 newborns in southern Stockholm during 12 months (October 2003-June 2004; August 2004-October 2004) were analysed for CMV DNA by TaqMan based real-time PCR. Hearing deficit was assessed by otoacoustic emission (OAE) within a newborn screening programme. 12 infants out of 6060 or 0.2% (95% CI 0.1-0.3%) had congenital CMV infection. One boy among the 12 infected infants had unilateral hearing loss, indicating that the risk of hearing loss is greatly increased (about 20 times) in CMV infected infants. No child developed ocular complications such as chorioretinopathy during 3 y of follow-up. Congenital CMV has an impact on child health but can easily be overlooked due to lack of signs in the neonatal period. Surveillance for congenital CMV is important in addition to programmes for prevention and treatment.
Related Concept Videos
Cytomegalovirus Disease
Cryptococcal Meningitis
Hearing
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...

